Enhanced function of immuno-isolated islets in diabetes therapy byco-encapsulation with an anti-inflammatory drug

Tram T. Dang, Anh V. Thai, Joshua Cohen, Jeremy E. Slosberg, Karolina Siniakowicz, Joshua Doloff, Minglin Ma, Jennifer Hollister-Lock, Katherine M. Tang, Zhen Gu, Hao Cheng, Gordon C. Weir, Robert Langer, Daniel G. Anderson

Research output: Contribution to journalArticle

Abstract

Immuno-isolation of islets has the potential to enable the replacement of pancreatic function in diabetic patients. However, host response to the encapsulated islets frequently leads to fibrotic overgrowth with subsequent impairment of the transplanted grafts. Here, we identified and incorporated anti-inflammatory agents into islet-containing microcapsules to address this challenge. Invivo subcutaneous screening of 16 small molecule anti-inflammatory drugs was performed to identify promising compounds that could minimize the formation of fibrotic cell layers. Using parallel non-invasive fluorescent and bioluminescent imaging, we identified dexamethasone and curcumin as the most effective drugs in inhibiting the activities of inflammatory proteases and reactive oxygen species in the host response to subcutaneously injected biomaterials. Next, we demonstrated that co-encapsulating curcumin with pancreatic rat islets in alginate microcapsules reduced fibrotic overgrowth and improved glycemic control in a mouse model of chemically-induced type I diabetes. These results showed that localized administration of anti-inflammatory drug can improve the longevity of encapsulated islets and may facilitate the translation of this technology toward a long-term cure for type I diabetes.

Original languageEnglish (US)
Pages (from-to)5792-5801
Number of pages10
JournalBiomaterials
Volume34
Issue number23
DOIs
StatePublished - Jul 1 2013

Fingerprint

Medical problems
Encapsulation
Curcumin
Anti-Inflammatory Agents
Type 1 Diabetes Mellitus
Capsules
Alginate
Biomaterials
Grafts
Pharmaceutical Preparations
Rats
Screening
Cells
Biocompatible Materials
Islets of Langerhans
Imaging techniques
Dexamethasone
Molecules
Oxygen
Reactive Oxygen Species

Keywords

  • Anti-inflammatory drugs
  • Curcumin
  • Diabetes
  • Encapsulated islets
  • Fibrotic overgrowth
  • Host response

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Enhanced function of immuno-isolated islets in diabetes therapy byco-encapsulation with an anti-inflammatory drug. / Dang, Tram T.; Thai, Anh V.; Cohen, Joshua; Slosberg, Jeremy E.; Siniakowicz, Karolina; Doloff, Joshua; Ma, Minglin; Hollister-Lock, Jennifer; Tang, Katherine M.; Gu, Zhen; Cheng, Hao; Weir, Gordon C.; Langer, Robert; Anderson, Daniel G.

In: Biomaterials, Vol. 34, No. 23, 01.07.2013, p. 5792-5801.

Research output: Contribution to journalArticle

Dang, TT, Thai, AV, Cohen, J, Slosberg, JE, Siniakowicz, K, Doloff, J, Ma, M, Hollister-Lock, J, Tang, KM, Gu, Z, Cheng, H, Weir, GC, Langer, R & Anderson, DG 2013, 'Enhanced function of immuno-isolated islets in diabetes therapy byco-encapsulation with an anti-inflammatory drug', Biomaterials, vol. 34, no. 23, pp. 5792-5801. https://doi.org/10.1016/j.biomaterials.2013.04.016
Dang, Tram T. ; Thai, Anh V. ; Cohen, Joshua ; Slosberg, Jeremy E. ; Siniakowicz, Karolina ; Doloff, Joshua ; Ma, Minglin ; Hollister-Lock, Jennifer ; Tang, Katherine M. ; Gu, Zhen ; Cheng, Hao ; Weir, Gordon C. ; Langer, Robert ; Anderson, Daniel G. / Enhanced function of immuno-isolated islets in diabetes therapy byco-encapsulation with an anti-inflammatory drug. In: Biomaterials. 2013 ; Vol. 34, No. 23. pp. 5792-5801.
@article{7bd4c4e28d414e5b9a40e57324f7fa6e,
title = "Enhanced function of immuno-isolated islets in diabetes therapy byco-encapsulation with an anti-inflammatory drug",
abstract = "Immuno-isolation of islets has the potential to enable the replacement of pancreatic function in diabetic patients. However, host response to the encapsulated islets frequently leads to fibrotic overgrowth with subsequent impairment of the transplanted grafts. Here, we identified and incorporated anti-inflammatory agents into islet-containing microcapsules to address this challenge. Invivo subcutaneous screening of 16 small molecule anti-inflammatory drugs was performed to identify promising compounds that could minimize the formation of fibrotic cell layers. Using parallel non-invasive fluorescent and bioluminescent imaging, we identified dexamethasone and curcumin as the most effective drugs in inhibiting the activities of inflammatory proteases and reactive oxygen species in the host response to subcutaneously injected biomaterials. Next, we demonstrated that co-encapsulating curcumin with pancreatic rat islets in alginate microcapsules reduced fibrotic overgrowth and improved glycemic control in a mouse model of chemically-induced type I diabetes. These results showed that localized administration of anti-inflammatory drug can improve the longevity of encapsulated islets and may facilitate the translation of this technology toward a long-term cure for type I diabetes.",
keywords = "Anti-inflammatory drugs, Curcumin, Diabetes, Encapsulated islets, Fibrotic overgrowth, Host response",
author = "Dang, {Tram T.} and Thai, {Anh V.} and Joshua Cohen and Slosberg, {Jeremy E.} and Karolina Siniakowicz and Joshua Doloff and Minglin Ma and Jennifer Hollister-Lock and Tang, {Katherine M.} and Zhen Gu and Hao Cheng and Weir, {Gordon C.} and Robert Langer and Anderson, {Daniel G.}",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.biomaterials.2013.04.016",
language = "English (US)",
volume = "34",
pages = "5792--5801",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "23",

}

TY - JOUR

T1 - Enhanced function of immuno-isolated islets in diabetes therapy byco-encapsulation with an anti-inflammatory drug

AU - Dang, Tram T.

AU - Thai, Anh V.

AU - Cohen, Joshua

AU - Slosberg, Jeremy E.

AU - Siniakowicz, Karolina

AU - Doloff, Joshua

AU - Ma, Minglin

AU - Hollister-Lock, Jennifer

AU - Tang, Katherine M.

AU - Gu, Zhen

AU - Cheng, Hao

AU - Weir, Gordon C.

AU - Langer, Robert

AU - Anderson, Daniel G.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Immuno-isolation of islets has the potential to enable the replacement of pancreatic function in diabetic patients. However, host response to the encapsulated islets frequently leads to fibrotic overgrowth with subsequent impairment of the transplanted grafts. Here, we identified and incorporated anti-inflammatory agents into islet-containing microcapsules to address this challenge. Invivo subcutaneous screening of 16 small molecule anti-inflammatory drugs was performed to identify promising compounds that could minimize the formation of fibrotic cell layers. Using parallel non-invasive fluorescent and bioluminescent imaging, we identified dexamethasone and curcumin as the most effective drugs in inhibiting the activities of inflammatory proteases and reactive oxygen species in the host response to subcutaneously injected biomaterials. Next, we demonstrated that co-encapsulating curcumin with pancreatic rat islets in alginate microcapsules reduced fibrotic overgrowth and improved glycemic control in a mouse model of chemically-induced type I diabetes. These results showed that localized administration of anti-inflammatory drug can improve the longevity of encapsulated islets and may facilitate the translation of this technology toward a long-term cure for type I diabetes.

AB - Immuno-isolation of islets has the potential to enable the replacement of pancreatic function in diabetic patients. However, host response to the encapsulated islets frequently leads to fibrotic overgrowth with subsequent impairment of the transplanted grafts. Here, we identified and incorporated anti-inflammatory agents into islet-containing microcapsules to address this challenge. Invivo subcutaneous screening of 16 small molecule anti-inflammatory drugs was performed to identify promising compounds that could minimize the formation of fibrotic cell layers. Using parallel non-invasive fluorescent and bioluminescent imaging, we identified dexamethasone and curcumin as the most effective drugs in inhibiting the activities of inflammatory proteases and reactive oxygen species in the host response to subcutaneously injected biomaterials. Next, we demonstrated that co-encapsulating curcumin with pancreatic rat islets in alginate microcapsules reduced fibrotic overgrowth and improved glycemic control in a mouse model of chemically-induced type I diabetes. These results showed that localized administration of anti-inflammatory drug can improve the longevity of encapsulated islets and may facilitate the translation of this technology toward a long-term cure for type I diabetes.

KW - Anti-inflammatory drugs

KW - Curcumin

KW - Diabetes

KW - Encapsulated islets

KW - Fibrotic overgrowth

KW - Host response

UR - http://www.scopus.com/inward/record.url?scp=84877797407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877797407&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2013.04.016

DO - 10.1016/j.biomaterials.2013.04.016

M3 - Article

VL - 34

SP - 5792

EP - 5801

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 23

ER -